Trials / Terminated
TerminatedNCT00776191
Randomized Multicenter Cross-over Study to Compare the Effect of Physioneal 35 to 40 on the Protein Metabolism
Randomized, Multicenter Cross-over Study in Investigating the Effect of Bicarbonate-based Solutions (Physioneal 35 vs. 40) on Protein Metabolism in Children and Adolescents on Chronic Peritoneal Dialysis
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- University of Erlangen-Nürnberg Medical School · Academic / Other
- Sex
- All
- Age
- 3 Months – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate an increase in protein metabolism during treatment with Physioneal 35® (containing lactate 10 mmol/l, calcium 1.75 mmol/l) compared to treatment with Physioneal 40® (containing lactate 15 mmol/l, calcium 1.25 mmol/l) in children and adolescents with end stage renal failure receiving peritoneal dialysis.
Detailed description
* Fat oxidation (13C-enrichment in expiration breath samples for U-C13-algae turnover) * Growth markers (plasma levels of IgF-1, IgF-BP3, leptin) * Biochemical markers of anabolism (plasma levels of total protein, albumin, transferrin) * Serum thyroid function (fT3, fT4, TSH) * Serum lipid status * Serum markers of calcium/phosphate metabolism (PTH, calcium, ionized calcium, phosphate, alkaline phosphatase) * Prevalence of metabolic acidosis/ alkalosis (venous sample), serum lactate * Safety parameters (such as normalized weekly Kt/v, parameters of glucose metabolism, parameters of hepatic function, parameters of calcium-phosphate-metabolism, physical examination incl. standing height, weight, assessment of complications related to peritoneal dialysis as peritonitis, exit infections and inguinal hernia) * Body composition (lean body mass and body fat mass/fluid)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Physioneal 35 | Physioneal 35® for eight weeks, followed by Physioneal 40® for eight weeks |
| DRUG | Physioneal 40 | Physioneal 40® for eight weeks followed by Physioneal 35® for eight weeks |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2008-10-21
- Last updated
- 2015-06-04
Locations
5 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00776191. Inclusion in this directory is not an endorsement.